Citations

Clear

4847 citation(s) found for "Yu, Eric".

Abstract 2248: Common TDP1 polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium
Lohavanichbutr, Pawadee, Field, John K. , Haura, Eric B. , Hung, Rayjean J., Kohno, Takashi , Landi, Maria Teresa , Schabath, Matthew B. , Tardón, Adonina , Yoshida, Kazushi, Zong, Xuchen, Chen, Chu , Sakoda, Lori C. , Amos, Christopher I. , Arnold, Susanne M. , Christiani, David C. , Davies, Michael P.A. , Hung, Rayjean J., Liu, Geoffrey , Marcus, Michael W. , O’Kane, Grainne M. , Shiraishi, Kouya , Slone, Stacey , Yang, Ping , Zhang, Ruyang , Weiss, Noel S , Field, John K , Tardón, Adonina , Schabath, Matthew B

Mayo Clinic

Cancer Research | July 31, 2017 | Volume: 77 | Issue: 13_Supplement | Pages: 2248-2248

10.1158/1538-7445.am2017-2248 Get It

Abstract Introduction: DNA topoisomerase inhibitors (e.g. etoposide, irinotecan, teniposide, topotecan) are commonly used for treating small cell lung cancer (SCLC). Tyrosyl-DNA phosphodiesterase (TDP1) plays a role in repairing DNA damage caused by DNA topoisomerase inhibitors and it is believed to be responsible for resistance to this class of drugs. The purpose of this study was to determine whether common TDP1 polymorphisms are associated with overall survival among SCLC patients. Method: Two common TDP1 SNPs (rs942190 and rs2401863, r2(European)=0.63 and r2(East Asian)=0.26) were analyzed in 898 patients from 10 studies in the International Lung Cancer Consortium, conducted in the U.S., Canada, Japan, Italy, Spain and the United Kingdom. Genotype data were obtained from either the OncoArray Consortium or other existing genome-wide association studies. Cox proportional hazard regression models with robust standard error were used to evaluate genotype associations for overall survival at 36 months post-diagnosis, adjusting for age, sex, race and tumor stage. Results: Patients homozygous for the minor allele (GG) of TDP1 SNP rs942190 were associated with poorer survival compared to those carrying both major alleles (AA), with a hazard ratio (HR) of 1.36 (95% confidence interval (CI): 1.07-1.72, p-value=0.01), but there was no association with survival for patients with the heterozygous genotype (HR=1.02, 95% CI: 0.83-1.27, p-value=0.83). For rs2401863, patients carrying both minor alleles (CC) tended to have better survival than patients carrying AA alleles, but this was within the limits of chance given no significant association (HR=0.79, 95% CI: 0.61-1.02, p-value=0.07). In addition, multi-tissue expression quantitative trait loci (eQTL) analyses from the Genotype-Tissue Expression Project indicated a potential effect of rs942190 on lung tissue, with higher TDP1 gene expression for the GG than AG or AA genotypes. Conclusion: We found that among SCLC patients the TDP1 rs942190 GG genotype was associated with poor overall survival. Further study could determine if this genotype can serve as a predictive marker for the treatment efficacy of DNA topoisomerase inhibitors in SCLC. Citation Format: Pawadee Lohavanichbutr, Lori C. Sakoda, Christopher I. Amos, Susanne M. Arnold, David C. Christiani, Michael P. Davies, John K. Field, Eric B. Haura, Rayjean J. Hung, Takashi Kohno, Maria Teresa Landi, Geoffrey Liu, Yi Liu, Michael W. Marcus, Grainne M. O'Kane, Matthew B. Schabath, Kouya Shiraishi, Stacey A. Slone, Adonina Tardón, Ping Yang, Kazushi Yoshida, Ruyang Zhang, Xuchen Zong, Noel S. Weiss, Chu Chen. Common TDP1 polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2248. doi:10.1158/1538-7445.AM2017-2248
Abstract 1287: Multigene panel testing and risk estimates in 10,233 ovarian cancer cases
Lilyquist, Jenna , LaDuca, Holly , Moore, Raymond M. , Dolinsky, Jill S. , Goldgar, David E. , Polley, Eric C. , Shimelis, Hermela , Hu, Chunling , Hart, Steven N. , Couch, Fergus J.

Mayo Clinic

Cancer Research | July 31, 2017 | Volume: 77 | Issue: 13_Supplement | Pages: 1287-1287

10.1158/1538-7445.am2017-1287 Get It

Abstract Germline pathogenic variants in BRCA1 and BRCA2 account for 10% of ovarian cancer (OC), including ovarian, fallopian tube, and primary peritoneal carcinomas. Pathogenic variants in BRIP1, RAD51C, RAD51D, and other cancer predisposition genes have been observed in another 2% to 5% of OCs. However, the specific genes associated with OC and estimates of risk associated with pathogenic variants in the individual genes are not well defined. We sought to determine the relevance of multigene panel testing results for OC cases. The study was focused on 140,449 individuals, including 10,233 OC cases, receiving clinical panel testing of cancer predisposition genes. Standardized relative risks (SRR) for pathogenic variants in 18 cancer predisposition genes were estimated using reference controls from the Exome Aggregation Consortium (ExAC). The median (range) age at diagnosis of OC was 57 (21-90) years. OC cases were 76.2% Caucasian, 3.6% African American, 4.6% Asian, 4.7% Hispanic, and 10.9% unknown/other. Among the 10,233 OC cases, 1391 (13.6%) had pathogenic mutations, including 1032 pathogenic mutations among the 7793 Caucasian OC cases (13.2%). Using the non-Finnish European ExAC (excluding TCGA samples) reference controls, the allele frequency for all pathogenic variants in each gene was summed and compared to the frequency of mutations in the Caucasian OC cases. Pathogenic variants in the known OC predisposition genes: BRCA1, BRCA2, BRIP1, MSH2, MSH6, RAD51C, and RAD51D were associated with a high risk of OC (SRR>4.0). Additionally, significant associations were observed for pathogenic variants in suspected OC risk genes ATM and PALB2 (SRR=2.06 and 2.78, respectively). This study identified several genes routinely screened on multigene panel testing that confer high or moderate risks of OC. Associations with known OC predisposition genes were confirmed. In addition, this study provides evidence that PALB2 is a moderate risk OC gene, and that ATM may confer lower to moderate risks of OC. If confirmed in future studies, these risks should be carefully considered in future screening and management of OC patients. In contrast, BARD1 and genes in the MRN complex were not associated with clinically relevant risks of OC. Citation Format: Jenna Lilyquist, Holly LaDuca, Eric Polley, Hermela Shimelis, Chunling Hu, Raymond Moore, Steven N. Hart, Fergus J. Couch, Jill Dolinsky, David E. Goldgar. Multigene panel testing and risk estimates in 10,233 ovarian cancer cases [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1287. doi:10.1158/1538-7445.AM2017-1287
Development of quality metrics for ambulatory pediatric cardiology: Infection prevention
Johnson, Jonathan N. , Barrett, Cindy, Franklin, Wayne H., Graham, Eric M. , Halnon, Nancy , Hattendorf, Brandy, Krawczeski, Catherine D. , McGovern, James J., Vinocur, Jeffrey M. , Chowdhury, Devyani , Anderson, Jeffrey , O’Connor, Matthew J. , Schultz, Amy , Vinocur, Jeffrey M

Mayo Clinic

Congenital Heart Disease | July 25, 2017 | Volume: 12 | Issue: 6 | Pages: 756-761

10.1111/chd.12519 | PMID 28741863 Get It

Postoperative stereotactic radiosurgery for limited brain metastases: are we ready for prime time?
Lo, Simon S. , Brown, Paul D. , Foote, Matthew , Chao, Samuel T. , Chang, Eric L. , Sahgal, Arjun

Mayo Clinic

Expert Review of Anticancer Therapy | July 24, 2017 | Volume: 17 | Issue: 9 | Pages: 775-777

10.1080/14737140.2017.1358090 | PMID 28737065 Get It

Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study
Kinnunen, Kirsi M. , Cash, David M. , Poole, Teresa, Frost, Chris , Benzinger, Tammie L.S. , Ahsan, R. Laila, Leung, Kelvin K., Cardoso, M. Jorge , Modat, Marc , Malone, Ian B. , Morris, John C. , Bateman, Randall J. , Marcus, Daniel S. , Goate, Alison , Salloway, Stephen , Correia, Stephen , Chhatwal, Jasmeer P. , Mayeux, Richard , Martins, Ralph N. , Farlow, Martin R. , Saykin, Andrew J. , Jack, Clifford R. , Schofield, Peter R. , Weiner, Michael W. , Ringman, John M. , Thompson, Paul M. , Masters, Colin L. , Rossor, Martin N. , Ourselin, Sébastien , Fox, Nick C. , (DIAN), Dominantly Inherited Alzheimer Network, Sperling, Reisa Anne , Brickman, Adam M. , Ghetti, Bernardino , McDade, Eric , Rowe, Christopher Cleon , (DIAN), Dominantly Inherited Alzheimer Network, Jack, Clifford R , Saykin, Andrew J , Schofield, Peter R , Thompson, Paul M , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Fox, Nick C , Morris, John C , Cash, David M , Goate, Alison M

Mayo Clinic

Alzheimer's & Dementia | July 22, 2017 | Volume: 14 | Issue: 1 | Pages: 43-53

10.1016/j.jalz.2017.06.2268 | PMID 28738187 Get It

Abstract Introduction Identifying at what point atrophy rates first change in Alzheimer's disease is important for informing design of presymptomatic trials. Methods Serial T1‐weighted magnetic resonance imaging scans of 94 participants (28 noncarriers, 66 carriers) from the Dominantly Inherited Alzheimer Network were used to measure brain, ventricular, and hippocampal atrophy rates. For each structure, nonlinear mixed‐effects models estimated the change‐points when atrophy rates deviate from normal and the rates of change before and after this point. Results Atrophy increased after the change‐point, which occurred 1–1.5 years (assuming a single step change in atrophy rate) or 3–8 years (assuming gradual acceleration of atrophy) before expected symptom onset. At expected symptom onset, estimated atrophy rates were at least 3.6 times than those before the change‐point. Discussion Atrophy rates are pathologically increased up to seven years before “expected onset”. During this period, atrophy rates may be useful for inclusion and tracking of disease progression.
Local Cellular Responses to Titanium Dioxide from Orthopedic Implants
Yao, Jie , Lewallen, Eric A. , Trousdale, William H. , Xu, Wei , Thaler, Roman , Salib, Christopher G. , Reina, Nicolas , Lewallen, David G. , Wijnen, André J. van , Yao, Jie J, Abdel, Matthew P. , van Wijnen, Andre J

Mayo Clinic

BioResearch Open Access | July 21, 2017 | Volume: 6 | Issue: 1 | Pages: 94-103

10.1089/biores.2017.0017 | PMID 29034133 Get It

Solar insolation in springtime influences age of onset of bipolar I disorder
Bauer, Michael , Glenn, Tasha , Aleksandrovich, M. A., Angelopoulos, Elias, Ardau, Raffaella , Ayhan, Yavuz , Baethge, Christopher , Bharathram, S. R., Bauer, Rita, Becerra‐Palars, C., Belmaker, Robert H. , Berk, Michael , Bersudsky, Yuly, Bicakci, Ş., Bjella, Thomas , Bossini, Letizia, Cabrera, Jorge , Cheung, Eric Yat Wo, Zompo, Maria Del , Donix, Markus , Étain, Bruno , Fountoulakis, Konstantinos Ν. , Frye, Mark A. , González‐Pinto, Ana , Gottlieb, John F. , Grof, Paul , Harima, Hirohiko, Henry, Chantal , Isometsä, Erkki , Janno, Sven , Kapczinski, Flávio , Kardell, Mathias, Khaldi, S., Kliwicki, Sebastian , Kot, Timur L., Krogh, Rikke, Kunz, Maurício , Lafer, Beny , Landén, Mikael , Larsen, Erik Roj , Lewitzka, Ute , Licht, Rasmus Wentzer , López‐Jaramillo, Carlos , Manchia, Mirko , Marsh, Wendy , Melle, Ingrid , Meza-Urzúa, Fátima, Ming, Mok Yee, Monteith, Scott , Morken, Gunnar , Mosca, Enrica, Muñoz, Rodrigo , Mythri, Starlin Vijay , Nacef, F., Nery, Fabiano G. , Nielsen, René Ernst , O’Donovan, Claire , Omrani, Adel, Osher, Yamima , Sørensen, Helle Østermark , Ouali, Uta , Ruiz, Yolanda Pica, Pilhatsch, Maximilian , Pinna, Marco , Ponte, Francisco Diego Rabelo da, Quiroz, Danilo , Ramesar, Raj , Rasgon, Natalie , Reddy, M. S., Reif, Andreas , Ritter, Philipp , Sagduyu, Kemal, Scippa, Ângela Miranda, Severus, Emanuel , Simhandl, Christian , Stein, Dan J. , Strejilevich, Sergio , Sulaiman, Ahmad Hatim , Suominen, Kirsi, Tagata, Hiromi , Tatebayashi, Yoshitaka , Vaaler, A. E., Veeh, Julia, Vieta, Eduard , Viswanath, Biju , Yoldi‐Negrete, María , Zetin, Mark, Zgueb, Yosra , Whybrow, Peter C., Bauer, M , Bellivier, F , Etain, B , Vieta, E , Alda, Martin , Andreassen, Ole A. , Baune, Bernhard , Bellivier, Frank , Bicakci, Ş., Birabwa‐Oketcho, Harriet , Dodd, Seetal , Fagiolini, Andrea , König, Barbara , MacQUEEN, GLENDA M. , Martínez‐Cengotitabengoa, Mónica , MUNOZ, RODRIGO A. , Nadella, R K , Rybakowski, Janusz K , Subramaniam, M , Tondo, Leonardo , Torrent, Carla , Vaaler, A. E., Stein, Dan J , López-Jaramillo, Carlos , Fountoulakis, Konstantinos N , Reif, Andreas , Viswanath, Biju , Berk, Michael , Manchia, Mirko , Ouali, U , Ritter, P , Strejilevich, S , Yoldi-Negrete, M , Bıçakcı, Şule

Mayo Clinic

Acta Psychiatrica Scandinavica | July 19, 2017 | Volume: 136 | Issue: 6 | Pages: 571-582

10.1111/acps.12772 | PMID 28722128 Get It

ObjectiveTo confirm prior findings that the larger the maximum monthly increase in solar insolation in springtime, the younger the age of onset of bipolar disorder.MethodData were collected from 5536 patients at 50 sites in 32 countries on six continents. Onset occurred at 456 locations in 57 countries. Variables included solar insolation, birth‐cohort, family history, polarity of first episode and country physician density.ResultsThere was a significant, inverse association between the maximum monthly increase in solar insolation at the onset location, and the age of onset. This effect was reduced in those without a family history of mood disorders and with a first episode of mania rather than depression. The maximum monthly increase occurred in springtime. The youngest birth‐cohort had the youngest age of onset. All prior relationships were confirmed using both the entire sample, and only the youngest birth‐cohort (all estimated coefficientsP< 0.001).ConclusionA large increase in springtime solar insolation may impact the onset of bipolar disorder, especially with a family history of mood disorders. Recent societal changes that affect light exposure (LEDlighting, mobile devices backlit withLEDs) may influence adaptability to a springtime circadian challenge.
Bronchoscopic Management of Airway Compression due to Fibrosing Mediastinitis
Kern, Ryan , Peikert, Tobias, Edell, Eric S. , Mullon, John J., Midthun, David E. , Utz, James P., Maldonado, Fabien , Edell, Eric, Mullon, John, Midthun, David, Utz, James, Kern, R

Mayo Clinic

Annals of the American Thoracic Society | July 18, 2017 | Volume: 14 | Issue: 8 | Pages: 1353-1355

10.1513/annalsats.201610-782rl | PMID 28719233 Get It

Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length
Ammann, Eric M. , Wright, Kara, Link, Brian K. , Shanafelt, Tait D. , McDowell, Bradley D. , Chrischilles, Elizabeth A. , Link, Brian K

Mayo Clinic

Leukemia & Lymphoma | July 18, 2017 | Volume: 59 | Issue: 3 | Pages: 643-649

10.1080/10428194.2017.1349905 | PMID 28718694 Get It